Tuesday, November 29, 2016 12:52:35 PM
This is a REAL company with REAL products. Nyloxin has made a huge difference in my life and I started using the Pet Pain-Away in my 13-year old dog with amazing results.
You keep saying "zero revenues" - that's not true. The revenues are low, but they exist. They did $300K in sales last year and about $70K last quarter. That may sound abysmal to you, but it's higher sales than over 100 other biotech companies that really have zero sales in the hope of a future product. Nutra Pharma is creating sales while they're working on their potential blockbuster drugs. They did receive Orphan Designation on their Multiple Sclerosis drug and they will be moving into trials shortly.
You can be as negative as you want, but this is an amazing opportunity at these prices and I'm buying as much as I can down here.
GLTYA
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM